A cystic fibrosis patient says she may have to leave her island home unless a medicine is made available on the NHS.
Hannah McDiarmid, 23, who lives on Skye, currently has to make a three-hour each way trip to Raigmore Hospital in Inverness every other month for treatment.
When she develops an infection, a frequent hazard for those with cystic fibrosis, she stays there as an inpatient for a fortnight at a time while she undergoes intensive IV antibiotic treatment.
She is considering moving from the island where her family has lived for six generations as the long journeys are taking their toll.
However she believes if the drug Orkambi were available on the NHS it could benefit fellow sufferers across Scotland and save her from having to move.
She is backing Cystic Fibrosis Trust’s campaign for better access to medicines ahead of a debate in the Scottish Parliament on Tuesday evening.
Ms McDiarmid said: “I love Skye and one part of my family has always lived here. I studied Gaelic on the island and work part-time here at the archive centre and at Visit Scotland as the area is so important to me, but the journey is such a strain on us all. Medical research is really changing the way cystic fibrosis can now be treated and there is a medicine called Orkambi that could potentially help me.
“I just wish this was available on the NHS as it could make my life easier and could potentially mean I could remain on Skye with my family rather than have to live closer to the hospital.”
Cystic fibrosis is a debilitating life-shortening illness that creates a build-up of sticky mucus that causes progressive lung damage.
Ms McDiarmid, who was diagnosed with the condition when she was 17 weeks old, has previously undergone operations for polyps in her nose, suffers stomach problems, has chronic fatigue and most recently has been coughing up blood due to haemoptysis. The Cystic Fibrosis Trust said Orkambi is a precision medicine that could benefit more than 330 people in Scotland.